By gene analysis of 14 cervical cancer cell lines selected from the GDSC (Genomics of Cancer Drug Sensitivity) database, FGF18 significantly reduced the resistance of patients to cisplatin (161, 162). The gene discussed is FGF18; the disease is cervical carcinoma.